Friday, 22 January 2021

Shadowfax, SpiceXpress to arrange speedy transportation of COVID-19 vaccines in India

21 December 2020 | News

Shadowfax plans to deploy a fleet of over 250 refrigerated vehicles.

Source credit: Shutterstock

Source credit: Shutterstock

Shadowfax, the leading integrated 3PL services provider based in Bengaluru, has announced a strategic partnership with SpiceXpress, the largest cargo Airline in India to provide a seamless solution in transporting the temperature sensitive COVID-19 vaccine.

Shadowfax plans to deploy a fleet of over 250 refrigerated vehicles, which will provide a speedy and reliable transportation solution for vaccine delivery through a sustainable cold chain network.

For the COVID-19 vaccine movement, Shadowfax will provide logistics support to cover first mile pickups and last mile deliveries through a verified network of delivery partners operating across 500+ cities covering 7000+ pin codes in India. 

Commenting on this partnership, Rahul Kumar, Founding team member and Head, Network Partnerships, Shadowfax, said, “We are proud to partner with SpiceXpress for transporting the COVID vaccine and helping it reach people. Agility, speed, and precise handling will be essential considering the sensitive nature of the vaccine. We are geared up with our technology, people, and delivery expertise to ensure timely and safe deliveries across our extensive network. It has been a tough year and playing a role in bringing relief makes us immensely elated and energised.

It is vital to have the right partnership when undertaking a task this critical. In SpiceXpress we have found the synergies that will allow us to deliver the vaccine safely and seamlessly. We will handle ground services such as transportation to/from manufacturers, warehouses, airports and consumption points, packing, storage, and warehousing, at prescribed temperature across 500+ cities. We will deploy a fleet of refrigerated vehicles to ensure requisite temperatures are maintained throughout the delivery cycle.”


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls